Stock APLS APELLIS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Apellis Pharmaceuticals, Inc.

Equities

APLS

US03753U1060

Market Closed - Nasdaq
Other stock markets
 03:59:50 2024-05-30 pm EDT 		5-day change 1st Jan Change
40.73 USD -0.92% Intraday chart for Apellis Pharmaceuticals, Inc. +2.65% -31.96%
May. 24 Apellis Pharmaceuticals, Sobi Say Pegcetacoplan Reduces Post-Transplant Kidney Diseases MT
May. 24 Apellis Pharmaceuticals, Inc. Announces Positive One-Year Data from Phase 2 Study of Pegcetacoplan in Post-Transplant Recurrence of C3G and IC-MPGN Presented as Late-Breaker at ERA Congress CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
APELLIS PHARMACEUTICALS, INC.
Biopharmaceuticals
-0.92%+2.65%-31.96%-53.14%+88.30% 4.99B
Bearish
Bearish
Neutral

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. APLS Stock
  4. Charts Apellis Pharmaceuticals, Inc.
  5. Comparison Chart